Upload Image (Max 20MB per Image)
Bristol-Myers Squibb will acquire Amylin for $31.00 per share in cash, pursuant to a cash tender offer and second step merger, or a total buying price nearing $5.3bn. The acquisition value includes Amylin's debt proceeds and a contractual ...
Tags: Bristol-Myers Squibb, Amylin, Amylin's debt proceeds